BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND RSPO2, Q6UXX9, 340419, ENSG00000147655, MGC43342, MGC35555
7 results:

  • 1. rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway.
    Bi Y; Zhang L; Song Y; Sun L; Mulholland MW; Yin Y; Zhang W
    Gastroenterol Hepatol; 2024 Apr; 47(4):352-365. PubMed ID: 37437654
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. rspo2 silence inhibits tumorigenesis of nasopharyngeal carcinoma by ZNRF3/Hedgehog-Gli1 signal pathway.
    Wang Z; Wang Y; Ma X; Dang C
    Life Sci; 2021 Oct; 282():119817. PubMed ID: 34273374
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (rspo2).
    Xu Y; Ge K; Lu J; Huang J; Wei W; Huang Q
    Biomed Pharmacother; 2017 Sep; 93():334-343. PubMed ID: 28651234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. rspo2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Roles of miR-196a on gene regulation of neuroendocrine tumor cells.
    Li SC; Shi H; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
    Mol Cell Endocrinol; 2015 Sep; 412():131-9. PubMed ID: 26052033
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
    Ahn SM; Jang SJ; Shim JH; Kim D; Hong SM; Sung CO; Baek D; Haq F; Ansari AA; Lee SY; Chun SM; Choi S; Choi HJ; Kim J; Kim S; Hwang S; Lee YJ; Lee JE; Jung WR; Jang HY; Yang E; Sung WK; Lee NP; Mao M; Lee C; Zucman-Rossi J; Yu E; Lee HC; Kong G
    Hepatology; 2014 Dec; 60(6):1972-82. PubMed ID: 24798001
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.